Bausch + Lomb Initiates Clinical Trial Evaluating New Cohesive Ophthalmic Viscosurgical Device (OVD)

Bausch + Lomb announced that it has initiated a clinical trial evaluating the safety and efficacy of a new cohesive ophthalmic viscosurgical device (OVD) intended to provide surgeons with a new option in the continuum of cohesive and dispersive viscoelastics.

“This is the second new OVD that we are working to bring to the U.S. market,” Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in a company news release. “We know that surgeons need a variety of viscosurgical properties from which to choose based on their clinical techniques and preferences, and we are committed to providing these options as part of our broader commitment to continuously deliver meaningful innovation to our customers and their patients.”